Literature DB >> 26949902

[Prehospitale analgesia in adults].

Björn Hossfeld, Susanne Holsträter, Michael Bernhard, Lorenz Lampl, Matthias Helm, Martin Kulla.   

Abstract

After securing vital function, treatment of pain is an important aspect in emergency medical care. Irrespective of the underlying disease or injury, pain is an important warning symptom of the body and the most common reason for an emergency alert notification. A patient assesses quality of care and success of prehospital care using the criteria of the extent of pain relief he experiences. Since mild pain does not usually lead to an emergency alert, the criteria apply mainly to treatment of severe and very severe pain. Pain perception varies from individual to individual. Accordingly, assessment of pain intensity is the very first step in pain therapy. The Numeric Rating Scale (NRS) ranging from 0 (no pain) to 10 (worst pain imaginable) is suitable for pain assessment in adult emergency patients. Above a grade of 4, therapeutic intervention should be initiated with the goal of reducing pain to reach a value of <4, or at least to achieve a reduction by 3 points. The choice of analgesics that can be meaningfully used in pre-hospital emergency medicine is limited. The emergency physician should be aware of available drugs and administration routes. © Georg Thieme Verlag Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26949902     DOI: 10.1055/s-0042-101466

Source DB:  PubMed          Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther        ISSN: 0939-2661            Impact factor:   0.698


  1 in total

1.  Differences in pain treatment between surgeons and anaesthesiologists in a physician staffed prehospital emergency medical service: a retrospective cohort analysis.

Authors:  Stefan J Schaller; Felix P Kappler; Claudia Hofberger; Jens Sattler; Richard Wagner; Gerhard Schneider; Manfred Blobner; Karl-Georg Kanz
Journal:  BMC Anesthesiol       Date:  2019-01-31       Impact factor: 2.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.